Human Papillomavirus Detection from Human Immunodeficiency Virus-Infected Colombian Women's Paired Urine and Cervical Samples

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Munoz, Marina ^a,b,c   Camargo, Milena ^a,b   Soto De Leon, Sara C ^a,b   Sanchez, Ricardo ^a,c   Parra, Diana ^d   Pineda, Andrea C ^b   Sussmann, Otto ^d   Perez Prados, Antonio ^e   Patarroyo, Manuel E ^a,c   Patarroyo, Manuel A ^a,b  

^a FUNDACIÓN INSTITUTO DE INMUNOLOGÍA DE COLOMBIA FIDIC   (Colombia)

^b UNIVERSIDAD DEL ROSARIO   (Colombia)

^c UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^d Centro de Investigación Clínica ACISC Bogota   (Colombia)

^e PUBLIC UNIVERSITY OF NAVARRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; COLOMBIA; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MIXED INFECTION; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PREVALENCE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; URINALYSIS; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS;

ADULT; AGED; CERVIX UTERI; COINFECTION; COLOMBIA; DNA, VIRAL; FEMALE; HIV INFECTIONS; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 31; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 84873902711     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056509     Document Type: Article

References (41)

1. WHO (2011) GLOBAL HIV/AIDS RESPONSE: Epidemic update and health sector progress towards Universal Access. Global summary of the AIDS epidemic.
2. Feller L, Lemmer J, (2007) Aspects of immunopathogenic mechanisms of HIV infection. SADJ 62: 432-436.
3. Ferenczy A, Coutlee F, Franco E, Hankins C, (2003) Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: a review of recent developments. CMAJ 169: 431-434.
4. Clarke B, Chetty R, (2002) Postmodern cancer: the role of human immunodeficiency virus in uterine cervical cancer. Mol Pathol 55: 19-24.
5. Chirenje ZM, (2005) HIV and cancer of the cervix. Best Pract Res Clin Obstet Gynaecol 19: 269-276.
6. de Sanjose S, Palefsky J, (2002) Cervical and anal HPV infections in HIV positive women and men. Virus Res 89: 201-211.
7. WHO/ICO (2010) Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human Papillomavirus and Related Cancers in Colombia. Summary Report.
8. Moscicki AB, (2005) Impact of HPV infection in adolescent populations. J Adolesc Health 37: S3-9.
9. Brinkman JA, Jones WE, Gaffga AM, Sanders JA, Chaturvedi AK, et al. (2002) Detection of human papillomavirus DNA in urine specimens from human immunodeficiency virus-positive women. J Clin Microbiol 40: 3155-3161.
10. Heard I, (2009) Prevention of cervical cancer in women with HIV. Curr Opin HIV AIDS 4: 68-73.
11. Denny L, (2012) Cytological screening for cervical cancer prevention. Best Pract Res Clin Obstet Gynaecol 26: 189-196.
12. Del Mistro A, Chieco Bianchi L, (2001) HPV-related neoplasias in HIV-infected individuals. Eur J Cancer 37: 1227-1235.
13. Olmos M, Acosta J, Preciado S, Arias S, Ballesteros M, et al. (2007) Recomendaciones para la tamización de neoplasias del cuello uterino en mujeres sin antecedentes de patología cervical (preinvasora o invasora) en Colombia.Bogota D.C., Colombia: Instituto Nacional de Cancerología (INS). pp. 64.
14. Sehgal A, Gupta S, Parashari A, Sodhani P, Singh V, (2009) Urine HPV-DNA detection for cervical cancer screening: prospects and prejudices. J Obstet Gynaecol 29: 583-589.
15. Vorsters A, Micalessi I, Bilcke J, Ieven M, Bogers J, et al. (2012) Detection of human papillomavirus DNA in urine. A review of the literature. Eur J Clin Microbiol Infect Dis 31: 627-640.
16. Sellors JW, Lorincz AT, Mahony JB, Mielzynska I, Lytwyn A, et al. (2000) Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. CMAJ 163: 513-518.
17. Jong E, Mulder JW, van Gorp EC, Wagenaar JK, Derksen J, et al. (2008) The prevalence of human papillomavirus (HPV) infection in paired urine and cervical smear samples of HIV-infected women. J Clin Virol 41: 111-115.
18. Camargo M, Soto-De Leon SC, Sanchez R, Perez-Prados A, Patarroyo ME, et al. (2011) Frequency of human papillomavirus infection, coinfection, and association with different risk factors in Colombia. Ann Epidemiol 21: 204-213.
19. Munoz M, Camargo M, Soto-De Leon SC, Rojas-Villarraga A, Sanchez R, et al. (2012) The diagnostic performance of classical molecular tests used for detecting human papillomavirus. J Virol Methods 185: 32-38.
20. Gillison ML, Shah KV, (2003) Chapter 9: Role of mucosal human papillomavirus in nongenital cancers. J Natl Cancer Inst Monogr pp. 57-65.
21. Posso HJ, Wiesner C, Piñeros M, Hernando R, González M, et al. (2005) Acciones en el plan obligatorio de salud. Manual de normas técnico - administrativas para el programa de detección y control del cáncer de cuello uterino en el sistema general de seguridad en salud. II ed. Bogotá- Colombia. pp. 190.
22. Camargo M, Soto-De Leon S, Sanchez R, Munoz M, Vega E, et al. (2011) Detection by PCR of human papillomavirus in Colombia: Comparison of GP5+/6+ and MY09/11 primer sets. J Virol Methods 178: 68-74.
23. Cervantes J, Lema C, Hurtado L, Andrade R, Quiroga G, et al. (2003) Prevalence of human papillomavirus infection in rural villages of the Bolivian Amazon. Rev Inst Med Trop Sao Paulo 45: 131-135.
24. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, et al. (1985) Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230: 1350-1354.
25. Iftner T, Villa LL, (2003) Chapter 12: Human papillomavirus technologies. J Natl Cancer Inst Monogr pp. 80-88.
26. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ, (1995) The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76 (Pt 4):: 1057-1062.
27. Remmerbach TW, Brinckmann UG, Hemprich A, Chekol M, Kuhndel K, et al. (2004) PCR detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP5+/6+ primer sets. J Clin Virol 30: 302-308.
28. Fujinaga Y, Shimada M, Okazawa K, Fukushima M, Kato I, et al. (1991) Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction. J Gen Virol 72 (Pt 5):: 1039-1044.
29. Szostek S, Klimek M, Zawilinska B, Rys J, Kope J, et al. (2006) Detection of human papillomavirus in cervical cell specimens by hybrid capture and PCR with different primers. Acta Biochim Pol 53: 603-607.
30. Schmitt M, Dondog B, Waterboer T, Pawlita M, (2008) Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers. J Clin Microbiol 46: 1050-1059.
31. Depuydt CE, Boulet GA, Horvath CA, Benoy IH, Vereecken AJ, et al. (2007) Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types. J Cell Mol Med 11: 881-891.
32. Karlsen F, Kalantari M, Jenkins A, Pettersen E, Kristensen G, et al. (1996) Use of multiple PCR primer sets for optimal detection of human papillomavirus. J Clin Microbiol 34: 2095-2100.
33. Lee YM, Leu SY, Chiang H, Fung CP, Liu WT, (2001) Human papillomavirus type 18 in colorectal cancer. J Microbiol Immunol Infect 34: 87-91.
34. Sotlar K, Diemer D, Dethleffs A, Hack Y, Stubner A, et al. (2004) Detection and typing of human papillomavirus by e6 nested multiplex PCR. J Clin Microbiol 42: 3176-3184.
35. Castellsague X, Bosch FX, Munoz N, (2002) Environmental co-factors in HPV carcinogenesis. Virus Res 89: 191-199.
36. Moscicki AB, Schiffman M, Kjaer S, Villa LL, (2006) Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine 24 (Suppl 3):: S3/42-51.
37. D'Hauwers K, Depuydt C, Bogers JP, Stalpaert M, Vereecken A, et al. (2007) Urine versus brushed samples in human papillomavirus screening: study in both genders. Asian J Androl 9: 705-710.
38. Song ES, Lee HJ, Hwang TS, (2007) Clinical efficacy of human papillomavirus DNA detection in urine from patients with various cervical lesions. J Korean Med Sci 22: 99-104.
39. Cuschieri K, Nandwani R, McGough P, Cook F, Hogg L, et al. (2011) Urine testing as a surveillance tool to monitor the impact of HPV immunization programs. J Med Virol 83: 1983-1987.
40. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S, (2007) Human papillomavirus and cervical cancer. Lancet 370: 890-907.
41. Castle PE, Rodriguez AC, Porras C, Herrero R, Schiffman M, et al. (2007) A comparison of cervical and vaginal human papillomavirus. Sex Transm Dis 34: 849-855.